# Travere Therapeutics Inc. (TVTX) fundamentals

Data as of 2026-09-08. NASDAQ, United States. Sector: Healthcare / Biotechnology. Price $65.28, market value $6.2 billion.

## Valuation
- **P/E (trailing): n/a** (negative earnings). Travere Therapeutics Inc. reported negative earnings over the last twelve months, so the P/E is not meaningful; use price-to-sales, EV/EBITDA and free-cash-flow yield instead.
- **PEG: 0.12**. A PEG of 0.12 means the P/E is low relative to expected earnings growth: the market is not paying much for that growth.
- **Price / sales: 10.4×**. Each dollar of revenue is priced at 10.4×, a level that requires very high margins or very fast growth to justify.
- **Price / book: 61.1×**. The shares trade at 61.1× book value; most of the value is in earnings power and intangibles rather than the balance sheet.

## Profitability
- **Operating margin: -6.8%**. Operating margin is negative: the business loses money before interest and tax.
- **Net margin: -5.2%**. The company reported a net loss over the last twelve months.
- **Return on equity: -22.2%**. Return on equity is negative because earnings are negative.
- **Return on assets: -7.2%**. Each dollar of assets produces -7.2% of profit.

## Growth
- **Revenue growth (1 yr): 110.5%** (3-yr 64.9%/yr, 5-yr 19.9%/yr). Revenue grew 110.5% over the last year, against 19.9% a year compounded over five years: growth is accelerating.
- **EPS growth (1 yr): 92.9%**. Earnings per share rose 92.9%, slower than revenue, so margins compressed.

## Financial health
- **Current ratio: 2.74** (quick 2.74). Current assets cover the next year's liabilities 2.74 times.
- **Altman Z-score: 8.81**. A Z-score of 8.81 places the company in the safe zone for bankruptcy risk.
- **Piotroski F-score: 5/9**. 5 of 9 checks pass: mixed.

## Dividends
- **Dividend: none**. Travere Therapeutics Inc. does not currently pay a dividend.

## Price and momentum
- **Total return (1 yr): 208.7%** (YTD 70.8%, 3-mo 42.5%). The shares are up 208.7% over twelve months including dividends.
- **From 52-week high: -4.0%** (213.2% above the low). Trading within 5% of its 52-week high.
- **200-day average: above**. The price sits above its 200-day moving average, the usual definition of an uptrend.
- **RSI (14-day): 57**. An RSI of 57 is neutral.
- **Beta (1 yr): 1.49** (volatility 71%). Beta of 1.49 against the S&P 500: the shares move much more than the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=TVTX · Page: https://foliofundamentals.com/stocks/tvtx

Not investment advice.